Combinatorial treatment with testosterone and E2 prevented the development of high-grade prostatic intraepithelial neoplasia (HGPIN) or prostate cancer following ERα knockdown (182). This evidence concerns the gene ESR1 and prostate intraepithelial neoplasia.